InsiderClue
Insiders · Profile

Myers Scott Dunseth

Director at Zentalis Pharmaceuticals · Chief Executive Officer at Viridian Therapeutics, Inc.\DE. Filing since 13 Mar 2023. CIK 0001356256

ZNTL Zentalis Pharmaceuticals, Inc. Director · 1 trade VRDN Viridian Therapeutics, Inc.\DE Chief Executive Officer · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ZNTL Zentalis Pharmaceuticals, Inc.
30 Apr 2025
Director
Bought
21,000
$29.37K
8.1%
VRDN Viridian Therapeutics, Inc.\DE
12 Apr 2023
Chief Executive Officer
Bought
4,000
$101.48K
1.6%
VRDN Viridian Therapeutics, Inc.\DE
13 Mar 2023
Chief Executive Officer
Bought
5,500
$160.32K
2.2%
3 decisions on file.